These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11273784)

  • 1. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic gene.
    Fontanellas A; Mazurier F; Belloc F; Taine L; Dumain P; Morel C; Ged C; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 1999; 1(5):322-30. PubMed ID: 10738549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
    Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H
    J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful gene therapy of mice with congenital erythropoietic porphyria].
    de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
    Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer.
    Moreau-Gaudry F; Ged C; Barbot C; Mazurier F; Boiron JM; Bensidhoum M; Reiffers J; de Verneuil H
    Hum Gene Ther; 1995 Jan; 6(1):13-20. PubMed ID: 7703283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
    Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
    Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
    Pan D; Stroncek DF; Whitley CB
    J Gene Med; 2004 Dec; 6(12):1293-303. PubMed ID: 15538732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation.
    Géronimi F; Richard E; Redonnet-Vernhet I; Lamrissi-Garcia I; Lalanne M; Ged C; Moreau-Gaudry F; De Verneuil H
    Stem Cells; 2003; 21(4):472-80. PubMed ID: 12832700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.
    Robert-Richard E; Moreau-Gaudry F; Lalanne M; Lamrissi-Garcia I; Cario-André M; Guyonnet-Dupérat V; Taine L; Ged C; de Verneuil H
    Am J Hum Genet; 2008 Jan; 82(1):113-24. PubMed ID: 18179890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells].
    de Verneuil H; Moreau-Gaudry F; Ged C
    Transfus Clin Biol; 1997; 4(3):263-6. PubMed ID: 9264783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
    Moreau-Gaudry F; Mazurier F; Bensidhoum M; Ged C; de Verneuil H
    Blood; 1995 Mar; 85(6):1449-53. PubMed ID: 7888667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
    Nimgaonkar MT; Bahnson AB; Boggs SS; Ball ED; Barranger JA
    Gene Ther; 1994 May; 1(3):201-7. PubMed ID: 7584082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
    Bedel A; Taillepierre M; Guyonnet-Duperat V; Lippert E; Dubus P; Dabernat S; Mautuit T; Cardinaud B; Pain C; Rousseau B; Lalanne M; Ged C; Duchartre Y; Richard E; de Verneuil H; Moreau-Gaudry F
    Am J Hum Genet; 2012 Jul; 91(1):109-21. PubMed ID: 22795135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.